Peripheral Arterial Disease Trial, Recruiting (NCT05902923)

Peripheral Arterial Disease Trial, Recruiting NCT05902923 Sponsor: iVascular S.L.U. Condition: Peripheral Arterial Disease

Printed from Voxsanity (voxsanity.com.au) — NCT05902923 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Peripheral Arterial Disease

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who are over 18 years old.
People who understand what the procedure involves and are willing to sign a consent form before joining the study.
People whose affected blood vessel(s) are located in the kidney, hip/pelvic, or leg arteries.
People whose condition is suitable for treatment with one or more of the specific medical devices being studied in this trial, as determined by the trial site.

Who may not be able to join:

People whose blood vessel size or shape would not allow the study devices to be used safely or correctly.
People who have a known allergy or medical reason to avoid any of the study devices or their components.
People who are pregnant, breastfeeding, or who are capable of becoming pregnant and are not using adequate contraception.
People whose life expectancy is less than 12 months.
People who have any surgical procedure planned within 30 days after the study procedure.
People whose condition is considered medically unstable at the time the procedure is due to take place.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 9 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +32 479 64 37 60

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05902923

Sponsor: iVascular S.L.U.

Phase: Not Applicable

Status: Recruiting

Condition: Peripheral Arterial Disease

Trial contact: +32 479 64 37 60

More information: https://clinicaltrials.gov/study/NCT05902923

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who are over 18 years old.
People who understand what the procedure involves and are willing to sign a consent form before joining the study.
People whose affected blood vessel(s) are located in the kidney, hip/pelvic, or leg arteries.
People whose condition is suitable for treatment with one or more of the specific medical devices being studied in this trial, as determined by the trial site.

Who may not be able to join:

People whose blood vessel size or shape would not allow the study devices to be used safely or correctly.
People who have a known allergy or medical reason to avoid any of the study devices or their components.
People who are pregnant, breastfeeding, or who are capable of becoming pregnant and are not using adequate contraception.
People whose life expectancy is less than 12 months.
People who have any surgical procedure planned within 30 days after the study procedure.
People whose condition is considered medically unstable at the time the procedure is due to take place.

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 9 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

iVascular S.L.U.

Registry

ClinicalTrials.gov

Start date

1 August 2023

Est. completion

1 August 2025

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Freedeom from SAEs and SADEs (Primary Safety Endpoint); Technical success rate (Primary Efficacy Endpoint)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 9 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov